CeriBell Inc (CBLL)

Currency in USD
18.31
+0.62(+3.50%)
Closed·
18.310.00(0.00%)
·
Earnings results expected in 7 days
CBLL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
18.0018.72
52 wk Range
10.8524.33
Key Statistics
Prev. Close
17.69
Open
18
Day's Range
18-18.72
52 wk Range
10.85-24.33
Volume
531.82K
Average Volume (3m)
363.33K
1-Year Change
29.4908%
Book Value / Share
3.74
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CBLL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
26.86
Upside
+46.68%
Members' Sentiments
Bearish
Bullish
ProTips
Impressive gross profit margins

CeriBell Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 26.86
(+46.68% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Canaccord
Buy25.00+36.54%28.00MaintainMay 12, 2026
TD Cowen
Buy29.00+58.38%-MaintainApr 15, 2026
Canaccord Genuity
Buy30.00+63.84%29.00MaintainDec 17, 2025
BTIG
Buy30.00+63.84%-MaintainDec 15, 2025
Raymond James
Buy26.00+42.00%19.00MaintainDec 09, 2025

CeriBell Inc Earnings Call Summary for Q1/2026

  • Q1 2026 revenue rose 29% YoY to $26.5M; EPS loss of $0.52 missed forecast of $0.36 by 44%, driven by higher litigation and expansion costs.
  • Operating expenses surged 36% to $43.9M; gross margin remained strong at 87% despite increased sales and marketing investments.
  • Company raised FY 2026 revenue guidance to $112M-$116M from $111M-$115M, though expects Q2-Q3 sequential moderation due to seasonal factors.
  • Launched new products targeting neonate and pediatric markets; management remains confident in achieving cash flow breakeven with existing reserves.
  • Shares declined 0.94% to $20.2 post-earnings; stock up 60% over six months with analyst price targets ranging from $24 to $32.
Last Updated: 11/05/2026, 22:40
Read Full Transcript

Earnings

Latest Release
May 11, 2026
EPS / Forecast
-0.52 / -0.36
Revenue / Forecast
26.5M / --
EPS Revisions
Last 90 days

CBLL Income Statement

Compare CBLL to Peers and Sector

Metrics to compare
CBLL
Peers
Sector
Relationship
P/E Ratio
−11.5x−2.8x−0.4x
PEG Ratio
−0.39−0.020.00
Price/Book
4.9x2.2x2.6x
Price / LTM Sales
7.3x2.3x3.0x
Upside (Analyst Target)
47.0%51.0%56.0%
Fair Value Upside
Unlock13.6%9.1%Unlock

CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient’s EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
10.54M27.77%186.41M
Other Institutional Investors
35.49M72.23%627.87M
Public Companies & Retail Investors
0.000.00%0.00
Total
46.03M100.00%814.28M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
FMR LLC12.78%4,849,81185,793
TPG Capital, L.P.9.92%3,765,05466,604

People Also Watch

33.27
CEVA
+1.90%
43.47
BAND
+11.06%
4.190
CAPR
+8.83%
68.690
AXTI
+13.67%
390.76
CIEN
+3.64%

FAQ

What Is the CeriBell (CBLL) Stock Price Today?

The CeriBell stock price today is 18.31 USD.

What Stock Exchange Does CeriBell Trade On?

CeriBell is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for CeriBell?

The stock symbol for CeriBell is "CBLL."

What Is the CeriBell Market Cap?

As of today, CeriBell market cap is 671.21M USD.

What Is CeriBell's Earnings Per Share (TTM)?

The CeriBell EPS (TTM) is -1.63.

When Is the Next CeriBell Earnings Date?

CeriBell will release its next earnings report on Aug 10, 2026.

From a Technical Analysis Perspective, Is CBLL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has CeriBell Stock Split?

CeriBell has split 0 times.

How Many Employees Does CeriBell Have?

CeriBell has 327 employees.

What is the current trading status of CeriBell (CBLL)?

As of Aug 03, 2026, CeriBell (CBLL) is trading at a price of 18.31 USD, with a previous close of 17.69 USD. The stock has fluctuated within a day range of 18.00 USD to 18.72 USD, while its 52-week range spans from 10.85 USD to 24.33 USD.

What Is CeriBell (CBLL) Price Target According to Analysts?

The average 12-month price target for CeriBell is 26.86 USD, with a high estimate of 32 USD and a low estimate of 24 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +46.68% Upside potential.

What Is the CBLL Premarket Price?

CBLL's last pre-market stock price is 17.71 USD. The pre-market share volume is 12,720.00, and the stock has decreased by 0.02, or 0.11%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.